These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25976347)

  • 1. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis on coronary angiography is a marker for accelerated cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Cheng R; Kransdorf EP; Wei J; Patel JK; Kobashigawa JA; Azarbal B
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28786501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodeling 1 year after cardiac transplantation.
    Li H; Tanaka K; Chhabra A; Oeser B; Kobashigawa JA; Tobis JM
    J Heart Lung Transplant; 2007 Jan; 26(1):56-62. PubMed ID: 17234518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease.
    Kitabata H; Tanaka A; Kubo T; Takarada S; Kashiwagi M; Tsujioka H; Ikejima H; Kuroi A; Kataiwa H; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Hirata K; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    Am J Cardiol; 2010 Jun; 105(12):1673-8. PubMed ID: 20538113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.
    Takahashi T; Kobayashi Y; Saeed O; Vukelic S; Jorde UP; Shin JJ; Patel SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1678-1687. PubMed ID: 37454771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximab.
    Wang R; Moura LA; Lopes SV; Costa FD; Souza Filho NF; Fernandes TL; Salvatti NB; Faria-Neto JR
    Arq Bras Cardiol; 2015 Aug; 105(2):176-83. PubMed ID: 26107815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
    Mehra MR; Ventura HO; Jain SP; Ramireddy K; Ali A; Stapleton DD; Smart FW; Ramee SR; Collins TJ; White CJ
    J Am Coll Cardiol; 1997 May; 29(6):1339-44. PubMed ID: 9137233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Plaque Neovascularization by Optical Coherence Tomography: Ex Vivo Feasibility Study and In Vivo Observation in Patients With Angina Pectoris.
    Kume T; Okura H; Yamada R; Koyama T; Fukuhara K; Kawamura A; Imai K; Neishi Y; Uemura S
    J Invasive Cardiol; 2016 Jan; 28(1):17-22. PubMed ID: 26716590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound.
    Azarbal B; Cheng R; Vanichsarn C; Patel JK; Czer LS; Chang DH; Kittleson MM; Kobashigawa JA
    Circ Heart Fail; 2016 Jan; 9(1):e002252. PubMed ID: 26747860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Segmental Versus Longitudinal Intravascular Ultrasound Analysis for Pediatric Cardiac Allograft Vasculopathy.
    Kuhn MA; Burch M; Chinnock RE; Fenton MJ
    Transplant Proc; 2017 Oct; 49(8):1899-1902. PubMed ID: 28923645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.